Notalgia parestetika tanılı 25 hastanın klinik özellikleri ve tedavileri

Amaç: Notaljia parestetika (NP), sırtta kronik kaşıntı olarak ortaya çıkan nöropatik bir durumdur. Bu retrospektif çalışmanın amacı, NP tanısı alan hastaların özelliklerini incelemektir. Gereç ve Yöntem: Notaljia parestetikanın spinal veya periferik kökenini belirlemek üzere, yaşları 26-64 arasında (ortalama± 10.67 yıl; medyan: 47.17 yıl) toplam 25 kadın hasta çalışmaya alındı. Bulgular: Radyolojik incelemede hastaların %24’ünde diskopati, %32’sinde artroz ve %56’sında dejenerasyon gözlendi. Dermatolojik semptomlar ile manyetik rezonans görüntüleme pozitifliği arasında anlamlı bir ilişki bulunamadı (p=0.188). Hastaların tedavi programları fizik tedavi (%44), lokal enjeksiyon (%28), egzersiz tedavisi (%16) veya fizik tedavi ve kinezyoterapi (%12) şeklindeydi. Ağrı için subjektif ölçümler, ortalama bir görsel analog skala (VAS) ile doğrulandı ve nöropatik ağrıyı taramak için “Douleur Neuropathique 4” (DN4) anketi kullanıldı. Hastaların tedavi öncesi VAS skoru 7, tedavi sonrası VAS skoru 2 idi. Ortalama DN4 skoru tedaviden önce 7, tedaviden sonra 2 idi. Sonuç: NP nadir göriülen bir sendromdur. Bu çalışmada NP klinik özelliklerini ve tedavilerini derledik

Report on 25 Notalgia paresthetica cases: Clinical features and treatments

Objectives: Notalgia paresthetica (NP) is a neuropathic condition that manifests as a chronic itch on the back. The aim of this retrospective study was to examine the characteristics of patients diagnosed with NP. Methods: A total of 25 female patients, aged 26–64 years (mean±10.67 years; median 47.17 years), were studied to determine the spinal or peripheral origin of NP. Results: On radiological examination, discopathy was observed in 24% of the patients, arthrosis in 32%, and degeneration in 56%. There was no significant relationship found between dermatological symptoms and magnetic resonance imaging positivity (p=0.188). The patients’ treatment programs were based on either physical therapy (44%), local injection (28%), exercise therapy (16%), or physical therapy and kinesiotherapy (12%). Subjective measures for pain were validated with an average visual analog scale (VAS), and the “Douleur Neuropathique 4” (DN4) questionnaire was used to screen for neuropathic pain. The VAS score of the patients before treatment was 7, and after treatment was 2. The mean DN4 score was 7 before treatment and 2 after treatment. Conclusion: NP is a rare syndrome of unknown etiology. We aim in this study to analyse NP clinical properties and treatment.

PDF

___

1. Šitum M, Kolić M, Franceschi N, Pećina M. Notalgia paresthetica. Acta Clin Croat 2018;57(4):721–5.[CrossRef ]
2. Springall DR, Karanth SS, Kirkham N, Darley CR, Polak JM. Symptoms of notalgia paresthetica may be explained by increased dermal innervation. J Invest Dermatol 1991;97(3):555–61. [CrossRef ]
3. Savk E, Savk O, Bolukbasi O, Culhaci N, Dikicioğlu E, Karaman G, et al. Notalgia paresthetica: A study on pathogenesis. Int J Dermatol 2000;39(10):754–9. [CrossRef ]
4. Robbins BA, Rayi A, Ferrer-Bruker SJ. Notalgia Paresthetica. StatPearls. Available at: https://www.ncbi.nlm.nih.gov/ books/NBK470597/. Accesed Feb 24, 2022.
5. Pagliarello C, Fabrizi G, De Felici B, Casanova D, Feliciani C, Di Nuzzo S. Notalgia paresthetica: Factors associated with its perceived severity, duration, side, and localization. Int J Dermatol 2017;56(9):932–8. [CrossRef ]
6. Shin J, Kim YC. Neuropathic itch of the back: A case of notalgia paresthetica. Ann Dermatol 2014;26(3):392–4.
7. Savk O, Savk E. Investigation of spinal pathology in notalgia paresthetica. J Am Acad Dermatol 2005;52(6):1085–7.
8. Wang CK, Gowda A, Barad M, Mackey SC, Carroll IR. Serratus muscle stimulation effectively treats notalgia paresthetica caused by long thoracic nerve dysfunction: A case series. J Brachial Plex Peripher Nerve Inj 2009;4:17.
9. Tacconi P, Manca D, Tamburini G, Cannas A, Giagheddu M. Notalgia paresthetica following neuralgic amyotrophy: A case report. Neurol Sci 2004;25(1):27–9. [CrossRef ]
10. Chiriac A, Podoleanu C, Moldovan C, Stolnicu S. Notalgia paresthetica, a clinical series and review. Pain Pract 2016;16(5):E90–1. [CrossRef ]
11. Alcántara F, Feito M, Albizuri F, Beato M, De Lucas R. Notalgia paresthetica and multiple endocrine neoplasia syndrome 2A: A case report. Pediatr Dermatol 2016;33(5):e303–5.
12. Pleet AB, Massey EW. Notalgia paresthetica. Neurology 1978;28(12):1310–2. [CrossRef ]
13. Wallengren J, Klinker M. Successful treatment of notalgia paresthetica with topical capsaicin: Vehicle-controlled, double-blind, crossover study. J Am Acad Dermatol 1995;32(2 Pt 1):287–9. [CrossRef ]
14. Savk E, Bolukbasi O, Akyol A, Karaman G. Open pilot study on oxcarbazepine for the treatment of notalgia paresthetica. J Am Acad Dermatol 2001;45(4):630–2. [CrossRef ]
15. Maari C, Marchessault P, Bissonnette R. Treatment of notalgia paresthetica with botulinum toxin a: A doubleblind randomized controlled trial. J Am Acad Dermatol 2014;70(6):1139–41. [CrossRef ]
16. Machado LA, Maher CG, Herbert RD, Clare H, McAuley JH. The effectiveness of the McKenzie method in addition to first-line care for acute low back pain: A randomized controlled trial. BMC Med 2010;8:10. [CrossRef ]
17. Fleischer AB, Meade TJ, Fleischer AB. Notalgia paresthetica: Successful treatment with exercises. Acta Derm Venereol 2011;91(3):356–7. [CrossRef ]
18. Savk E, Savk O, Sendur F. Transcutaneous electrical nerve stimulation offers partial relief in notalgia paresthetica patients with a relevant spinal pathology. J Dermatol 2007;34(5):315–9. [CrossRef ]
19. Subasi V, Cakir T, Atasoy M. Efficacy of dry needling and kinesiotaping combination in the treatment of notalgia paresthetica: A case report. Turk J Phys Med Rehab 2016;62(3):273–6. [CrossRef ]
20. Huguen J, Brenaut E, Clerc CJ, Poizeau F, Marcorelles P, Quereux G, et al. Comparison of characteristics of neuropathic and non-neuropathic pruritus to develop a tool for the diagnosis of neuropathic pruritus: The NP5. Front Med (Lausanne) 2019;6:79. [CrossRef ]